Antibiotics - Pathogen Chart
Antibiotics - Pathogen Chart
Antibiotics - Pathogen Chart
Streptococcus spp. Enterobacter spp. GPC MRSA / MRSE (3%) GPB VRSA, VREF, VRE L. monocytogenes GPB
Salmonella spp.
Citrobacter spp.
MSSA / MSSE
N.meningitidis
P. aeruginosa
M. catarrhalis
H. influenzae
Shigella spp.
Serratia spp.
C. difficile
Klebsiella
C C C C C C C C
2
T T T T T T T T T T T T T T T
25%
30%
B. fragilis
E. coli
PHM321Y ANTIBIOTICS
N. gonorrhoeae
Piperacillin-Tazobactam
Cephalexin/Cefadroxil/Cefazolin
2
Cefuroxime/Cefprozil/Cefaclor
2
Cefoxitin
40%
Ceftriaxone/Cefotaxime
3
C C C C C C C C C C C C C S S S S S S S C
Ceftazidime
3 4
DIM
17%
Cefixime Cefepime
Ceftobiprole
DIM
DIM
30
%
Carbapenems (DIME)
5
O
3-13%
CO M M
Sulfamethoxazole-Trimethoprim Fluoroquinolones (CON) Resp. Fluoroquinolones (LM) Aminoglycosides (TAG) Metronidazole Clindamycin Macrolides (ACE) Linezolid
3 4
T C A C C T T
C L
C
30-50%
syn syn
syn
Oral anaerobes
Cidal or Static?
AC AC
Nitrofurantoin
syn
syn
Chloramphenicol
6
syn
syn
syn
syn
PO only; IV only, both the drug has weak coverage or there is high resistance (25%) against the drug Risk of resistance given if mentioned in class these bugs have the potential to produce BSBLs (SPACE PEK bugs) and Pip/Tazo is not effective against BSBLs Enterococcus faecium is more resistant than Enterococcus faecalis against these drugs (carbapenems are not effective against E. faecium) DIME = doripenem, imipenem-cilastatin, meropenem, ertapenem CON = ciprofloxacin, ofloxacin, norfloxacin; LM = levofloxacin, moxifloxacin; TAG = tobramycin, amikacin, gentamicin; ACE = azithromycin, clarithromycin, erythromycin TDM = tetracycline, doxycycline, minocycline syn = synergy ( 2x extent of killing compared to best agent alone) GPB = gram-positive bacilli GPC = gram-positive cocci GNB = gram-negative bacilli GNC = gram-negative cocci
1 2 3 5 4 6
Never use as a single agent: combine with aminoglycosides Only Ceftriaxone covers N. gonorrhoeae Only used in cystitis or recurrent UTI prophylaxis Glycopeptides: vancomycin, telavancin cidal against H. influenzae, S. pneumoniae, N. meningitides cidal against S. pnuemoniae, S. epidermis. Does not cover Proteus spp. = drug of choice against species (bold font) Atypical Organisms Stenotrophomonas maltophilia Pneumocystitis carinii (HIV)
weak or unreliable activity against pathogen, do not use as 1st line treatment
Mycoplasma pneumoniae
Legionella pneumoniae
Chlamydia trachomatis
Clamydia pneumoniae
Mycobacterium spp.
Rickettisia spp.
Brucella spp.
ORAL ANAEROBES Peptococcus Peptostreptococcus Fusobacterium Bacteroides spp. GNB THAT CAN PRODUCE BROAD SPECTRUM BETALACTAMASES (BSBLs) SPACE PEK:
Sulfamethoxazole-Trimethoprim Fluoroquinolones (CON) Fluoroquinolones (LM) Macrolides (ACE) Tetracyclines (TDM) Chloramphenicol Rifampin CO O L CO CO
syn
syn
syn
Serratia marcescens Pseudomonas aeruginosa Acinobacter spp. Citrobacter spp. Enterobacter spp.